Research Papers:
Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition
Metrics: PDF 2428 views | HTML 2912 views | ?
Abstract
Fei Shen1, Wen-Song Cai1, Zhe Feng1, Ji-wei Chen1, Jian-hua Feng1, Qi-cai Liu2, Yong-ping Fang3, Kun-ping Li3, Huan-qing Xiao1, Jie Cao1, Bo Xu1
1Department of General Surgery, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, P.R. China
2Experimental Medical Research Center, Guangzhou Medical University, Guangzhou, P.R. China
3Department of General Surgery, Huizhou First People's Hospital, Huizhou, P.R. China
Correspondence to:
Jie Cao, email: [email protected]
Bo Xu, email: [email protected]
Keywords: SPRY4-IT1, LncRNA, CRC, metastasis, EMT
Received: March 28, 2016 Accepted: June 17, 2016 Published: July 06, 2016
ABSTRACT
Colorectal cancer (CRC) remains one of the most common cancers worldwide. Increasing evidence indicates that SPRY4 intronic transcript 1 (SPRY4-IT1) regulate cell growth, differentiation, apoptosis, and cancer progression. However, the expression and function of SPRY4-IT1 in the progression of CRC remains largely unknown. Here, we reported that SPRY4-IT1 was upregulated in CRC. Increased SPRY4-IT1 expression in CRC was associated with larger tumor size and higher clinical stage. In vitro experiments revealed that SPRY4-IT1 knockdown significantly inhibited CRC cell proliferation by causing G1 arrest and promoting apoptosis, whereas SPRY4-IT1 overexpression promoted cell proliferation. Further functional assays indicated that SPRY4-IT1 overexpression significantly promoted cell migration and invasion by regulate the epithelial-mesenchymal transition (EMT). Taken together, our study demonstrates that SPRY4-IT1 could act as a functional oncogene in CRC, as well as a potential therapeutic target to inhibit CRC metastasis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10407